Discounting in economic evaluations: stepping forward towards optimal decision rules
The National Institute for Clinical Excellence has recently changed its guidelines on discounting costs and effects in economic evaluations. In common with most other regulatory bodies it now requires that health effects should be discounted at the same rate as costs. We show that the guideline leads to sub-optimal decisions because it fails to account for the changing value of health. NICE (and other regulatory bodies) should either use differential discounting or stipulate how the changing value of health should otherwise be dealt with. We also show how binding health service budget constraints should be incorporated in evaluations. Copyright © 2006 John Wiley & Sons, Ltd.
Year of publication: |
2007
|
---|---|
Authors: | Gravelle, Hugh ; Brouwer, Werner ; Niessen, Louis ; Postma, Maarten ; Rutten, Frans |
Published in: |
Health Economics. - John Wiley & Sons, Ltd., ISSN 1057-9230. - Vol. 16.2007, 3, p. 307-317
|
Publisher: |
John Wiley & Sons, Ltd. |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Discounting in economic evaluations : stepping forward towards optimal decision rules
Gravelle, Hugh, (2007)
-
Practice guidelines based on clinical and economic evidence
Rutten, Frans, (2005)
-
The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk
Bobinac, Ana, (2014)
- More ...